Fewer than 1% of uveal melanomas (UMs) occur in patients younger than 20 years.1 We report a histologically unusual UM in a child that was confirmed by the presence of a GNAQ somatic mutation.
Correspondence: Dr Levasseur, Department of Ophthalmology and Visual Sciences, University of British Columbia, 2550 Willow St, Vancouver, BC V5Z 3N9, Canada (email@example.com).
Published Online: April 9, 2013. doi:10.1001/jamaophthalmol.2013.2483
Conflict of Interest Disclosures: None reported.
Figure 1. Magnetic resonance images and clinical photograph. Axial non–fat-saturation T2-weighted (A), contrast-enhanced T1-weighted (B), and axial fat-saturation T1-weighted (C) magnetic resonance images show a uniformly enhancing right intraocular mass (asterisks in A and C). Note the deformation of the sclera adjacent to the mass (arrow in A), with no evidence of scleral, extrascleral, or optic nerve extension. The right globe is smaller than the left. The retinal detachment is well seen (arrowhead) on the T2-weighted image (A). D, The enucleated globe shows a solid cream-colored tumor in the posterior choroid. Note the complete retinal detachment and gelatinous subretinal fluid.
Figure 2. Histopathologic analysis and DNA sequence of GNAQ. A, Low-power photomicrograph shows regular polygonal-shaped cells with vascular spaces lined by tumor cells. Note the low nuclear to cytoplasmic ratio with vesicular nuclei, indistinct nucleoli, and lack of mitoses (hematoxylin-eosin, original magnification ×100). Inset, Scant melanin pigmentation is visible on Fontana-Masson staining (original magnification ×400). B, High-power photomicrograph shows the low nuclear to cytoplasmic ratio with vesicular nuclei, indistinct nucleoli, and lack of mitoses (hematoxylin-eosin, original magnification ×400). C, The melanoma stains strongly for Melan-A (avidin-biotin immunoperoxidase, hematoxylin counterstain, original magnification ×400). D, It also stains strongly for HMB-45 and S-100 protein (not shown) (avidin-biotin immunoperoxidase, hematoxylin counterstain, original magnification ×400). E, The DNA sequence shows the heterozygous CAA to CTA mutation in exon 5 of GNAQ, causing substitution of glutamine by leucine.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Ophthalmology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.